NCT05673239View on ClinicalTrials.gov

Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

1,008

Participants

Timeline

Start Date

January 15, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2024

Conditions
Renal Dialysis
Interventions
DRUG

Levocarnitine Injection

The patients in the test group were injected with 1-2g (10-20mg/kg) levocarnitine on each dialysis day

Trial Locations (1)

Unknown

The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou

All Listed Sponsors
lead

The First Affiliated Hospital of Zhejiang Chinese Medical University

OTHER